Show simple item record

dc.contributor.authorYang, Yu Chi
dc.contributor.authorBanuelos, Carmen Adriana
dc.contributor.authorMawji, Nasrin R
dc.contributor.authorWang, Jun
dc.contributor.authorKato, Minoru
dc.contributor.authorHaile, Simon
dc.contributor.authorMcEwan, Iain J
dc.contributor.authorPlymate, Stephen
dc.contributor.authorSadar, Marianne D
dc.date.accessioned2017-05-02T23:01:33Z
dc.date.available2017-05-02T23:01:33Z
dc.date.issued2016-09-01
dc.identifier.citationYang , Y C , Banuelos , C A , Mawji , N R , Wang , J , Kato , M , Haile , S , McEwan , I J , Plymate , S & Sadar , M D 2016 , ' Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancer ' , Clinical Cancer Research , vol. 22 , no. 17 , pp. 4466–4477 . https://doi.org/10.1158/1078-0432.CCR-15-2901en
dc.identifier.issn1078-0432
dc.identifier.otherPURE: 65918540
dc.identifier.otherPURE UUID: 3712c05c-8129-47e7-95ea-db55a4a528b8
dc.identifier.otherScopus: 84988654939
dc.identifier.urihttp://hdl.handle.net/2164/8599
dc.descriptionAcknowledgments The authors thank Kate Watt (University of Aberdeen, Aberdeen, Scotland) for technical support. The authors are also grateful to Country Meadows Senior Men's Golf Charity Classic for financial support of this research. Financial support: This research was supported by grants to MDS from the NCI (2R01CA105304), the Canadian Institutes of Health Research (MOP79308) and the US Army Medical Research and Materiel Command Prostate Cancer Research Program (E81XWH-11-1-0551). Research by IJM’s group was supported by the Chief Scientist’s Office of the Scottish Government (ETM-258 and -382). We are grateful to Country Meadows Senior Men’s Golf Charity Classic for financial support of this research.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofClinical Cancer Researchen
dc.rights© 2016 American Association for Cancer Research.en
dc.subjectandrogen receptoren
dc.subjectN-terminal domainen
dc.subjectEPIen
dc.subjectcastration-resistant prostate canceren
dc.subjectresistance mechanismsen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectChief Scientist Office (CSO)en
dc.subjectETM-258en
dc.subjectETM-382en
dc.subject.lccRC0254en
dc.titleTargeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate canceren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1158/1078-0432.CCR-15-2901
dc.date.embargoedUntil2017-05-02


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record